Journal of Chemical and Pharmaceutical Research (ISSN : 0975-7384)

header
Reach Us reach to JOCPR whatsapp-JOCPR +44 1625708989
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Original Articles: 2015 Vol: 7 Issue: 6

Process related and degradation impurities in anti-inflammatory drug Roflumilast

Abstract

A detail study was undertaken to investigate origin of Roflumilast drug substance related impurities. These impurities were synthetically prepared and characterized by IR, NMR and Mass, in order to have proper process control. These impurities are N-(3,5-Dichloropyridin-4-yl)-3,4-bis(difluoromethoxy)benzamide (Roflumilast impurity-I), 4-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-3-(difluoromethoxy)benzamide (Roflumilast impurity-II), 3,4-Bis(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)benzamide (Roflumilast impurity-III), 3- Cyclobutyl-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide (Roflumilast impurity-IV), 3-(But-3-en-1- yloxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide (Roflumilast impurity-V), 3- (Cyclopropylmethoxy)-4-(difluoromethoxy)-N-(pyridin-4-yl)benzamide (Roflumilast impurity-VI), N-(3- Chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide (Roflumilast impurity-VII) and 3,5- Dichloro-4-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamido]pyridine-1-oxide (Roflumilast impurity -VIII).